Q32 Bio Inc. (QTTB) stock
QTTBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$8.63+0.34 (+4.10%)
Close on Nov 17, 2026Market cap $256.91MP/E –Yield –
Earnings
Q32 Bio's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Mar 9, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
–
EPS, Q3 FY2026
-$0.26
-$0.60 a year earlier
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of Q32 Bio's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Mar 9, 2027Expected | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 4, 2026before the open | – | – | -$0.26 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 5, 2026before the open | – | – | -$0.44 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 5, 2026before the open | – | – | -$0.54 | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 10, 2026before the open | $53.74M | – | $4.58 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 13, 2025before the open | – | – | -$0.60 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 6, 2025before the open | – | – | -$0.78 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 8, 2025before the open | – | – | -$0.90 | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 11, 2025before the open | – | – | -$1.16 | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 7, 2024before the open | – | – | -$1.46 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 8, 2024before the open | – | – | -$1.42 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 9, 2024before the open | – | – | -$6.33 | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 27, 2024after the close | – | – | – | Release |
| Q3 FY2020ended Sep 30, 2020 | Nov 9, 2020before the open | – | – | – | Filing |
| Q1 FY2019ended Mar 31, 2019 | Apr 8, 2019after the close | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Q32 Bio has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Q32 Bio puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Q32 Bio filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Update
- Results
- News
- Update
- News
- Results
- Results
- News
- Update
- Results
- News
- Results
- Update
See a number that looks wrong?